youtube_live
Q3 2026 earnings • in 2 days
See detailschevron_right
INCY:NASDAQ
Incyte Corp
$113.31
arrow_downward
-2.07%(-2.40) 1D
$113.31
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 26, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INCY...
Open
$115.48
High
$115.92
Low
$112.74
Mkt. cap
22.97B
Avg. vol.
1.73M
Volume
0.00
P/E ratio
14.44
52-wk high
$132.58
52-wk low
$84.02
EPS
$7.85
Beta
0.74
Shares outstanding
202.70M
No. of employees
3K
Open
$115.48
High
$115.92
Low
$112.74
Mkt. cap
22.97B
Avg. vol.
1.73M
Volume
0.00
P/E ratio
14.44
52-wk high
$132.58
52-wk low
$84.02
EPS
$7.85
Beta
0.74
Shares outstanding
202.70M
No. of employees
3K
News stories
From web sources and news partners
Yahoo Finance
·
5 hours ago
Incyte Highlights Promising Early Data for ’890 and ’734 in GI Cancers
News Corp
·
10 hours ago
Incyte Corp. stock underperforms Monday when compared to competitors
TradingView
·
13 hours ago
INCY: Promising KRAS G12D and bispecific data strengthen late-stage GI cancer programs
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2.84K
Founded2002
HeadquartersWilmington, Delaware, United States
SectorBiotechnology
Websiteincyte.com